David Denton

Albert Bourla

Pharma

In Pfizer's trying year, CEO takes 35% pay cut to $21.6M

In a difficult year for Pfizer, in which its share price fell by 44%, CEO Albert Bourla’s compensation fell by 35%, from $33M to $21.6M in 2023.

Kevin Dunleavy Mar 15, 2024 9:09am

Pfizer

Pfizer unveils potential cost-cutting measure on low COVID sales

Aug 1, 2023 1:45pm

Moderna manufacturing site

$42M package for Meline as Moderna installs Gomez as new CFO

Apr 12, 2022 10:56am